COMPASS THERAPEUTICS: $180 MLN IN CASH AND MARKETABLE SECURITIES AT END OF Q2 2026, WHICH IS EXPECTED TO FUND OPERATIONS INTO 2028

Reuters · 2d ago

Please log in to view news